Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

Dysentery Clinical Trial

Official title:
A Randomized, Blinded, Single-center, Parallel Controlled , Phase Ⅱ Clinical Trial to Evaluate Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged From 3 Months to 5 Years Old

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate immunogenicity and safety of S.flexneriza-S.sonnei Bivalent Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04865497
Study type	Interventional
Source	Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Contact
Status	Completed
Phase	Phase 2
Start date	January 19, 2019
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02280044` - Efficacy of Rifaximin in Preventing Campylobacteriosis	Phase 2/Phase 3
Completed	`NCT01080716` - Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate	Phase 1/Phase 2
Completed	`NCT00490932` - New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects	Phase 4
Completed	`NCT01306383` - Solar Disinfection (SODIS) of Drinking Water for Use in Developing Countries or in Emergency Situations	N/A
Not yet recruiting	`NCT01638039` - Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections	N/A
Completed	`NCT03561181` - Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months	Phase 1
Recruiting	`NCT05156528` - Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years	Phase 3
Completed	`NCT01672580` - Social Network Interventions in Rural Honduras	N/A